Adverum Biotechnologies, Inc. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 8,333 | 0 | 10,333 | 2 K to 10.3 K (+416.65 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Schwartz Steven Daniel | Director | Grant | A | 0.00 | 8,333 | 0 | 376,264 | 367.9 K to 376.3 K (+2.26 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Grant | A | 0.00 | 8,333 | 0 | 531,322 | 523 K to 531.3 K (+1.59 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 8,333 | 0 | 28,044 | 19.7 K to 28 K (+42.28 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Scientific Of ... | Option Exercise | A | 4.80 | 188,000 | 902,400 | 188,000 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Gasmi Mehdi | Chief Scientific Of ... | Grant | A | 0.00 | 125,000 | 0 | 161,803 | 36.8 K to 161.8 K (+339.65 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Rubio Roman G. | SVP, Translational ... | Option Exercise | A | 4.80 | 75,000 | 360,000 | 75,000 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Rubio Roman G. | SVP, Translational ... | Grant | A | 0.00 | 50,000 | 0 | 165,650 | 115.7 K to 165.7 K (+43.23 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | Chief Medical Offic ... | Option Exercise | A | 4.80 | 75,000 | 360,000 | 75,000 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Barone Samuel B. | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 91,603 | 41.6 K to 91.6 K (+120.18 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Swartzburg Michael | Principal Accountin ... | Grant | A | 0.00 | 36,900 | 0 | 82,113 | 45.2 K to 82.1 K (+81.61 %) |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Braun Shirley | VP, Human Resources | Grant | A | 0.00 | 116,900 | 0 | 161,140 | 44.2 K to 161.1 K (+264.24 %) |
| Feb 01 2016 | AAVL | Adverum Biotechnol ... | Wachter Paul | Director | Grant | A | 0.00 | 3,334 | 0 | 19,711 | 16.4 K to 19.7 K (+20.36 %) |